Literature DB >> 21937199

Impaired cognitive inhibition in schizophrenia: a meta-analysis of the Stroop interference effect.

René Westerhausen1, Kristiina Kompus, Kenneth Hugdahl.   

Abstract

Schizophrenia has been consistently shown to be associated with impairment in executive functioning. However, although frequently treated as such, the term executive functioning does not refer to a unitary cognitive function; it rather represents a set of basic, lower-level cognitive sub-components, e.g. updating, shifting, and cognitive inhibition. This specification into sub-components allows for a further differentiation of the executive deficits found in schizophrenia. Focusing on the sub-component of cognitive inhibition, we here present a meta-analysis of interference effect as assessed with the Stroop Color-Word Interference paradigm. Including the results of 36 studies with 1081 schizophrenia patients and 1026 healthy control subjects, it was shown that schizophrenia patients exhibit an increased Stroop interference effect both in response time (mean effect size: M(g) = 0.43; 95% confidence interval, CI95%: 0.35-0.52) and accuracy (M(g) = 0.62; CI95%: 0.47-0.77) measures of interference. However, a meta-regression analysis revealed that the size of the effect varies depending on the version of the Stroop paradigm used. Regarding the response time measures of interference, studies using the classical card version of the paradigm showed a significantly larger effect size than studies using a single-trial computerized version of the paradigm (M(g) = 0.60 vs. M(g) = 0.19). Despite of the dissociation between the two versions of the paradigm, the results of the present meta-analysis indicate that the reported global deficits in executive functioning found to be associated with schizophrenia are at least partly due to a reduced ability of cognitive inhibition.
Copyright © 2011. Published by Elsevier B.V.

Entities:  

Mesh:

Year:  2011        PMID: 21937199     DOI: 10.1016/j.schres.2011.08.025

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  34 in total

1.  Cross-Disorder Cognitive Impairments in Youth Referred for Neuropsychiatric Evaluation.

Authors:  Alysa E Doyle; Pieter J Vuijk; Nathan D Doty; Lauren M McGrath; Brian L Willoughby; Ellen H O'Donnell; H Kent Wilson; Mary K Colvin; Deanna C Toner; Kelsey E Hudson; Jessica E Blais; Hillary L Ditmars; Stephen V Faraone; Larry J Seidman; Ellen B Braaten
Journal:  J Int Neuropsychol Soc       Date:  2017-08-04       Impact factor: 2.892

2.  An updated Italian normative dataset for the Stroop color word test (SCWT).

Authors:  A Brugnolo; F De Carli; J Accardo; M Amore; L E Bosia; C Bruzzaniti; S F Cappa; L Cocito; G Colazzo; M Ferrara; L Ghio; E Magi; G L Mancardi; F Nobili; M Pardini; R Rissotto; C Serrati; N Girtler
Journal:  Neurol Sci       Date:  2015-11-30       Impact factor: 3.307

3.  Behavioral response inhibition in psychotic disorders: diagnostic specificity, familiality and relation to generalized cognitive deficit.

Authors:  Lauren E Ethridge; Melanie Soilleux; Paul A Nakonezny; James L Reilly; S Kristian Hill; Richard S E Keefe; Elliot S Gershon; Godfrey D Pearlson; Carol A Tamminga; Matcheri S Keshavan; John A Sweeney
Journal:  Schizophr Res       Date:  2014-09-26       Impact factor: 4.939

4.  Anabolic-androgenic steroid abuse and cognitive impairment: Testosterone IMPAIRS biconditional task performance in male rats.

Authors:  Ruth I Wood; Rebecka O Serpa
Journal:  Behav Brain Res       Date:  2019-11-04       Impact factor: 3.332

5.  Dysfunctional Neural Processes Underlying Context Processing Deficits in Schizophrenia.

Authors:  Seung Suk Kang; Angus W MacDonald; Scott R Sponheim
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2019-04-10

6.  Minimal effects of prolonged smoking abstinence or resumption on cognitive performance challenge the "self-medication" hypothesis in schizophrenia.

Authors:  Douglas L Boggs; Toral S Surti; Irina Esterlis; Brian Pittman; Kelly Cosgrove; R Andrew Sewell; Mohini Ranganathan; Deepak Cyril D'Souza
Journal:  Schizophr Res       Date:  2017-04-06       Impact factor: 4.939

7.  European Psychiatric Association guidance on assessment of cognitive impairment in schizophrenia.

Authors:  Antonio Vita; Wolfgang Gaebel; Armida Mucci; Gabriele Sachs; Andreas Erfurth; Stefano Barlati; Federico Zanca; Giulia Maria Giordano; Louise Birkedal Glenthøj; Merete Nordentoft; Silvana Galderisi
Journal:  Eur Psychiatry       Date:  2022-09-05       Impact factor: 7.156

8.  Response inhibition and response monitoring in a saccadic double-step task in schizophrenia.

Authors:  Katharine N Thakkar; Jeffrey D Schall; Gordon D Logan; Sohee Park
Journal:  Brain Cogn       Date:  2015-03-10       Impact factor: 2.310

9.  Distinguishing patterns of impairment on inhibitory control and general cognitive ability among bipolar with and without psychosis, schizophrenia, and schizoaffective disorder.

Authors:  Milena Y Gotra; Scot K Hill; Elliot S Gershon; Carol A Tamminga; Elena I Ivleva; Godfrey D Pearlson; Matcheri S Keshavan; Brett A Clementz; Jennifer E McDowell; Peter F Buckley; John A Sweeney; Sarah K Keedy
Journal:  Schizophr Res       Date:  2020-07-14       Impact factor: 4.939

Review 10.  The 5 choice continuous performance test (5C-CPT): A novel tool to assess cognitive control across species.

Authors:  Savita G Bhakta; Jared W Young
Journal:  J Neurosci Methods       Date:  2017-07-25       Impact factor: 2.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.